NCT00006279View on ClinicalTrials.gov

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

Not specified

Study Completion Date

May 31, 2005

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

Trial Locations (1)

27713

Kathy George, Durham

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00006279 - The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months | Biotech Hunter | Biotech Hunter